Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.022
Sell
RSI(14)
49.855
Neutral
STOCH(KDJ)(9,3,3)
52.886
Neutral
ATR(14)
0.547
High Vlolatility
CCI(14)
20.637
Neutral
Williams %R
44.030
Buy
TRIX(12,20)
-0.128
Sell
StochRSI(14)
84.744
Buy
Search
enVVeno Medical Corp
NVNOAdd to Watchlist
10.570USD
-0.056-0.53%
Close 07-31 16:00（ET）Quotes delayed by 15 min
7.11MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-0.53%
5 Days
+1.73%
1 Month
-1.31%
6 Months
-11.40%
Year to Date
-5.86%
1 Year
+129.28%
Key Figures
10.520Open
10.520High
2.34KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.35%Turnover Ratio
10.626Prev. Close
10.520Low
16.71KTurnover
LossP/E Static
0.34P/B
0.00%Div Yield TTM
-56.45%ROA
196.70052wk High
0.79Volume Ratio
-21.82MNet Profit
673.00KShares
-1155.2209EPS TTM
1.09Beta
-60.65%ROE
8.67052wk Low
0.00%Amplitude
--Gross Margin
7.11MMarket Cap
-0.81Reward/Risk
5.40%Risk Rate
TradingKey Stock Score of enVVeno Medical Corp
Currency: USD Updated: 2026-07-31Key Insights
enVVeno Medical Corp's fundamentals are relatively weak, and its growth potential is high.Its valuation is considered fairly valued, ranking 212 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to remain stable.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
enVVeno Medical Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
enVVeno Medical Corp Highlights
StrengthsRisks
enVVeno Medical Corporation is a late clinical-stage medical device company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe chronic venous insufficiency (CVI) of the deep venous system of the leg. The Company’s lead product is the VenoValve, which is a surgical replacement venous valve that is being evaluated in a U.S. pivotal study. The VenoValve is implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The Company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the veins of the leg, and back to the heart and lungs.
Overvalued
The company’s latest PE is -0.01, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 184.36K shares, decreasing 34.20% quarter-over-quarter.
Analyst Rating
Based on
1
analysts
Strong Buy
Current Rating
30.000
Target Price
+188.46%
Upside Space
enVVeno Medical Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Strong Buy
Current Rating
30.000
Target Price
+188.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
enVVeno Medical Corp
NVNO
1
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
10.539
Buy
MA10
10.452
Buy
MA20
10.692
Sell
MA50
10.669
Sell
MA100
10.806
Sell
MA200
8.852
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
enVVeno Medical Corp Info
enVVeno Medical Corporation is a late clinical-stage medical device company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe chronic venous insufficiency (CVI) of the deep venous system of the leg. The Company’s lead product is the VenoValve, which is a surgical replacement venous valve that is being evaluated in a U.S. pivotal study. The VenoValve is implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The Company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the veins of the leg, and back to the heart and lungs.
Ticker SymbolNVNO
CompanyenVVeno Medical Corp
CEOBerman (Robert A)
Websitehttps://envveno.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of enVVeno Medical Corp (NVNO)?
The current price of enVVeno Medical Corp (NVNO) is 10.57.
What is the symbol of enVVeno Medical Corp?
The ticker symbol of enVVeno Medical Corp is NVNO.
What is the 52-week high of enVVeno Medical Corp?
The 52-week high of enVVeno Medical Corp is 196.70.
What is the 52-week low of enVVeno Medical Corp?
The 52-week low of enVVeno Medical Corp is 8.67.
What is the market capitalization of enVVeno Medical Corp?
The market capitalization of enVVeno Medical Corp is 7.11M.
Is enVVeno Medical Corp (NVNO) currently rated as Buy, Hold, or Sell?
According to analysts, enVVeno Medical Corp (NVNO) has an overall rating of STRONG BUY, with a price target of 30.00.
What is the Earnings Per Share (EPS TTM) of enVVeno Medical Corp (NVNO)?
The Earnings Per Share (EPS TTM) of enVVeno Medical Corp (NVNO) is -1157.08.